Global Chronic Aspergillosis Treatment Market to Surpass US$ 4,056.4 Million by 2028, Says Coherent Market Insights (CMI)
September 09, 2021 09:00 ET
|
CMI
SEATTLE, Sept. 09, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global chronic aspergillosis treatment market is estimated to be valued at US$ 2,916.3 million in 2021 and is...
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
May 27, 2021 07:00 ET
|
Pulmocide
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...
Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide
May 27, 2021 02:00 ET
|
Jeito Capital
Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide Jeito selects Pulmocide as its fourth investment since launching the fundPulmocide is a late-stage biopharma...
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
May 27, 2021 02:00 ET
|
Pulmocide
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...